反应性氧物种是血管痴呆症的潜在治疗点
Amanda Louise White1, Grant M Talkington1,2, Blake Ouvrier1,2
1Clinical Neuroscience Research Center, Department of Neurosurgery, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Biomolecules
|January 25, 2025
概括
血管痴呆症 (VaD) 涉及由于脑血管损伤而导致的认知衰退. 本综述探讨了活性氧物种 (ROS) 如何为VaD发展和潜在的治疗向做出贡献.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 病理生物学 病理生物学
背景情况:
- 血管性痴呆 (VaD) 是老年人中普遍存在的神经退行性疾病,其特征是认知能力下降.
- 它源于脑血管损伤和大脑血流受损.
- 目前对VaD的治疗选择有限,其精确的病理生物学仍在研究中.
研究的目的:
- 审查特定反应性氧物种 (ROS) 在VaD发展中的作用.
- 探索针对ROS作为VaD治疗策略的潜力.
主要方法:
- 文献综述专注于VaD的病理生物学.
- 在细胞和分子层面分析反应性氧物种 (ROS) 的作用.
- 检查潜在的治疗干预措施,以VaD中的ROS为目标.
主要成果:
- 反应性氧物种 (ROS) 通过线粒体,内皮体和脑血管层面的损伤,涉及到VaD的发展.
- 特定的ROS分子被确定为VaD病变发生的关键贡献者.
- 针对这些ROS为VAD提供了一个有前途的治疗途径.
结论:
- 反应性氧物种 (ROS) 在血管痴呆症 (VaD) 的病原发生中起着至关重要的作用.
- 准特定的ROS分子为管理VaD提供了潜在的治疗策略.
- 对ROS向治疗的进一步研究可能会导致对这种疾病的有效治疗方法.
更多相关视频
14:25Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
Published on: May 13, 2022
6.5K
05:16Author Spotlight: High-Throughput Measurement of Intracellular ROS Levels in Hepatocellular Lines
Published on: January 19, 2024
4.2K
相关概念视频
Electron Transport Chain: Complex I and II
10.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.7K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
167
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
167
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
